Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00098892%3A_____%2F16%3AN0000128" target="_blank" >RIV/00098892:_____/16:N0000128 - isvavai.cz</a>

Alternative codes found

RIV/27283933:_____/16:N0000010 RIV/61989592:15110/16:73580791

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Personality features, dissociation, self-stigma, hope, and the complex treatment of depressive disorder

Original language description

The study included 72 patients who were hospitalized for the pharmacoresistant major depression; 63 of them completed the study. The mean scores of BDI-II, BAI, subjCGI, and objCGI significantly decreased during the treatment. BDI-II relative change statistically significantly correlated with the total ISMI score, Discrimination Experience (ISMI subscale), and Harm Avoidance (TCI-R personality trait). According to stepwise regression, the strongest factors connected to BDI-II relative change were the duration of the disorder and Discrimination Experience (domain of ISMI). ObjCGI relative change significantly correlated with the level of dissociation (DES), the total ISMI score, hope in ADHS total score, and Self-Directedness (TCI-R). According to stepwise regression, the strongest factor connected to objCGI relative change was Discrimination Experience (domain of ISMI). The existence of comorbid personality disorder did not influence the treatment response. CONCLUSION: According to the results of the present study, patients with pharmacoresistant depressive disorders, who have had more experience with discrimination because of their mental struggles, showed a poorer response to treatment.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FL - Psychiatry, sexology

OECD FORD branch

—

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2016

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Neuropsychiatric Disease and Treatment

ISSN

1176-6328

e-ISSN

—

Volume of the periodical

12

Issue of the periodical within the volume

October

Country of publishing house

NZ - NEW ZEALAND

Number of pages

14

Pages from-to

2539-2552

UT code for WoS article

—

EID of the result in the Scopus database

—